Evidence map›Paper›PMID 33818527›Full record

ArticleEndoscopic ultrasound

Endoscopic management of concomitant biliary and duodenal malignant obstruction: Impact of the timing of drainage for one

Antoine Debourdeau, Fabrice Caillol, Christophe Zemmour, Jérome Polypo Winkler, Claire Decoster, Christian Pesenti, Jean-Philippe Ratone, Jean Marie Boher, Marc Giovannini

Open access · greenAbstract read
In one paragraph

Article in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Endoscopic ultrasound-guided gallbladder drainage for jaundice: Response to Vanella et al.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Antoine DebourdeauEndoscopy Unit, Paoli Calmette Institute, Marseille; Gastroenterology and Hepatology Unit, CHU, Montpellier University, Montpellier, France.
Fabrice CaillolEndoscopy Unit, Paoli Calmette Institute, Marseille, France.
Christophe ZemmourStatistics Unit, Paoli Calmette Institute, Marseille, France.
Jérome Polypo WinklerEndoscopy Unit, Paoli Calmette Institute; Gastroenterology and Hepatology Unit, Assistance Publique Hopitaux Marseille AP-HM, Aix Marseille University, Marseille, France.
Claire DecosterEndoscopy Unit, Paoli Calmette Institute; Gastroenterology and Hepatology Unit, Assistance Publique Hopitaux Marseille AP-HM, Aix Marseille University, Marseille, France.
Christian PesentiEndoscopy Unit, Paoli Calmette Institute, Marseille, France.
Jean-Philippe RatoneEndoscopy Unit, Paoli Calmette Institute, Marseille, France.
Jean Marie BoherStatistics Unit, Paoli Calmette Institute, Marseille, France.
Marc GiovanniniEndoscopy Unit, Paoli Calmette Institute, Marseille, France.
Institut Pprime · FRInstitut Paoli-Calmettes · FRAssistance Publique Hôpitaux de Marseille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesConcomitant biliary and duodenal malignant obstruction are a severe condition mainly managed by duodenal and biliary stenting, which can be performed simultaneously (SAMETIME) or in two distinct procedures (TWO-TIMES). We conducted a single-center retrospective study to evaluate the feasibility of a SAMETIME procedure and the impact of endoscopic ultrasound (EUS)-hepaticogastrostomy in double malignant obstructions. PATIENTS AND

methodsFrom January 1, 2011, to January 1, 2018, patients with concomitant malignant bilioduodenal obstruction treated endoscopically were included. The primary endpoint was hospitalization duration. The secondary endpoints were bilioduodenal reintervention rates, adverse event rates, and overall survival. Patients were divided into groups for statistical analysis: (i) divided according to the timing of biliary drainage: SAMETIME vs. TWO-TIMES group, (ii) divided based on the biliary drainage method: EUS-HG group underwent hepaticogastrostomy, while DUODENAL ACCESS group underwent endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic drainage (PCTD) or EUS-guided choledocoduodenostomy (EUS-CD).

resultsThirty-one patients were included (19 women, median age = 71 years). Stenosis was mainly related to pancreatic cancer (17 patients, 54.8%). Sixteen patients were in the SAMETIME group, and 15 were in the TWO-TIMES group. Biliary drainage was performed by EUS-HG in 11 (35.%) patients, PCTD in 11 (35.%), ERCP in 8 (25.8%) and choledoduodenostomy in 1. Thirty patients died during follow-up. The median survival was 77 days (9% confidence interval [37-140]). The mean hospitalization duration was lower in the SAMETIME group: 7.5 vs. 12.6 days, P = 0.04. SAMETIME group patients tended to have a lower complication than TWO-TIMES (26.7% vs. 56.3%, P = 0.10). The EUS-HG group tended to have a lower complication rate (5% vs. 18.2%, P = 0.07) and less biliary endoscopic revision (30% vs. 9.1%, P = 0.37) than DUODENAL ACCESS.

conclusionsSAMETIME drainage is associated with a lower hospital stay without increased morbidity. EUS-HG could provide better access because it did not exhibit a higher complication rate and showed a tendency toward better patency and fewer complications.

Indexed as

biliary drainagebiliary strictureERCPEUSEUS biliary drainagegastric outlet obstructionhepaticogastrostomypancreatic cancer

Identifiers

PMID33818527
PMCPMC8098836
OpenAlexW3146959483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.